Novo sues Lilly over 'deceptive' ads comparing GLP-1 drug doses
The two biggest players in the obesity market are headed to court. Novo Nordisk sued Eli Lilly on Tuesday over what it claims are “maliciously and deceptively false” ads comparing the highest doses of the ...
July 21, 2026 02:57 PM EDT R&DPharmaLaw Novo sues Lilly over 'deceptive' ads comparing GLP-1 drug doses Nicole DeFeudis Senior Reporter The two biggest players in the obesity market are headed to court. Novo Nordisk sued Eli Lilly on Tuesday over what it claims are “maliciously … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that